Takeda Pharmaceutical Company(MX:TAKN)
MX$345.000.00 (0.00%)
MX:TAKN
Takeda Pharmaceutical Company earnings date
MX$345.00
At close:0.00 (0.00%)
Takeda Pharmaceutical Company (TAKN) Q2 2022 Earnings Report
0 Followers
MX:TAKN Q2 2022 EPS Results
- Actual EPS
- MXN 2.49
- Consensus EPS
- MXN 2.49
- Beat/Miss
- Met expectations
- One Year Ago EPS
- -MXN 0.89
MX:TAKN Q2 2022 Revenue Results
- Actual Revenue
- MXN 134.73B
- Expected Revenue
- MXN 126.05B
- Beat/Miss
- Beat by +MXN 8.68B
- YoY Revenue Growth
- -5.56%
Earnings Announcement Details
- Quarter
- Q2 2022
- Date
- 10/27/2022
- Time
- Before Open
- Conference Call
- Thursday, October 27, 2022
MX:TAKN Upcoming Earnings
Takeda Pharmaceutical Company's next earnings date is estimated for January 28, 2027, based on past reporting schedules.
Q2 2022 Earnings Call Audio
MX:TAKN Q2 2022 Earnings Call
0:00 / 0:00
Q2 2022 Earnings Slide Deck
Q2 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:TAKN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Jan 28, 2027 | 2026 (Q3) | 2.64- | 3.96 | ― | ― |
| Oct 29, 2026 | 2026 (Q2) | 2.707.14 | -0.46 | 1636.00% (+7.60) | |
| Jul 30, 2026 | 2026 (Q1) | 3.144.18 | 4.91 | -14.77% (-0.72) | |
| May 13, 2026 | 2025 (Q4) | -1.39-0.91 | -4.24 | 78.51% (+3.33) | |
| Jan 29, 2026 | 2025 (Q3) | 2.533.96 | 0.91 | 334.69% (+3.05) | |
| Oct 30, 2025 | 2025 (Q2) | 1.30-0.46 | 3.53 | -113.16% (-4.00) | |
| Jul 29, 2025 | 2025 (Q1) | 3.164.91 | 3.77 | 30.05% (+1.13) | |
| May 08, 2025 | 2024 (Q4) | -0.52-4.24 | -0.13 | -3157.14% (-4.11) | |
| Jan 30, 2025 | 2024 (Q3) | 1.580.91 | 4.24 | -78.51% (-3.33) | |
| Oct 31, 2024 | 2024 (Q2) | 2.313.53 | -1.93 | 282.69% (+5.47) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
